Martha Goldberg Aronson - 01 Jun 2022 Form 4 Insider Report for CONMED Corp (CNMD)

Role: Director
Signature: /s/ Sarah M. Oliker for Martha Goldberg Aronson by Power of Attorney
Issuer symbol: CNMD
Transactions as of: 01 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 02 Jun 2022, 21:09:53 UTC
Previous filing: 09 Feb 2022
Next filing: 09 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CNMD	Common Stock	Options Exercise	$0	+812	+7.8%	$0.000000	11,275	01 Jun 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CNMD	Rsus (restricted Stock Units)	Options Exercise	$0	-812	-100%	$0.000000^*	0	01 Jun 2022	Common Stock	812	$0.000000	Direct	F1
transaction	CNMD	Options To Purchase Common Stock	Award	$0	+3,453		$0.000000	3,453	01 Jun 2022	Common Stock	3,453	$111.79	Direct	F2
transaction	CNMD	Rsus (restricted Stock Units)	Award	$0	+335		$0.000000	335	01 Jun 2022	Common Stock	335	$0.000000	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.
F2	The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.